Abstract
Background: Since 2008, the availability of the oral direct thrombin inhibitor dabigatran etexilate provides a further therapeutic alternative to injectable low-molecular-weight heparin (LMWH) for thromboprophylaxis following hip or knee replacement surgery. The intention of this study is to analyze patient preferences for this new oral thromboprophylaxis agent.
Methods: Face-to-face interviews were conducted with 73 doctors and nurses in 12 German hospitals, 195 current hip and knee replacement patients in six German rehabilitation hospitals, and 202 former thromboprophylaxis patients. Qualitative questions were complemented by a full-profile ranking-based conjoint analysis regarding alternative thromboprophylaxis regimens.
Results: Nearly 100% of the interviewed medical staff viewed the daily subcutaneous LMWH injection as a source of inconvenience for patients. However, both current and former patients perceived their discomfort to be much less intense. In contrast, the conjoint estimates of preferences showed that older and male patients in particular understated their levels of discomfort in a face-to-face interview situation and had a strong preference for oral anticoagulation.
Conclusions: Patients in Germany appear to have a positive preference for oral thromboprophylaxis after major orthopedic surgery.
Similar content being viewed by others
References
Colwell Jr CW. Thromboprophylaxis in orthopaedic surgery. Am J Orthop 2006; Suppl:1–9: quiz 10–1
Böttner F, Sulco TP, Sharrock NE, et al. Thromboprophylaxis after hip surgeries [in German]. Orthopäde 2001; 30: 890–6
Van Aken H, Bode C, Darius H, et al. Anticoagulation: the present and future. Clin Appl Thromb Hemost 2001; 7: 195–204
Hawkins D. Pharmacoeconomics of thrombosis management. Pharmacotherapy 2004; 24: 95–9S
Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2005; 126(3 Suppl.): 338–400S
AWMF. Inpatient and outpatient thromboprophylaxis in surgical and pre-surgical cases [in German; online]. Available from URL: http://www.uni-duesseldorf.De/awmf/ll/003-001.htm [Accessed 2009 Jan 5]
Lipp H-P, Goldinger A, Haussmann W, et al. Anti-thrombotics for therapy and prophylaxis of venous thromboembolism [in German]. Krankenhauspharmazie 2004; 25: 195–210,303-15
Eriksson BI, Dahl OE, Bueller HR, et al. A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost 2005; 3: 103–11
Eriksson BI, Dahl OE, Rosencher N, et al. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial [published erratum appears in Lancet 2007; 370: 2004]. Lancet 2007; 370: 949–56
Wilke T, Neumann K, Klapper U, et al. Oral anti-coagulation after hip or knee replacement surgery: a process-driven managerial pharmacoeconomic analysis in German hospitals [in German]. Orthopäde 2008; 37: 448–56
Statistical development of population and households [in German]. Publication VI A 1. Wiesbaden: Statistisches Bundesamt, 2007
Gustafsson A, Herrmann A, Huber F, editors. Conjoint measurement: methods and applications. Berlin: Springer, 2007
Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. Pharmacoeconomics 2008; 26(8): 661–77
Hait JF, Black WC, Babin BJ, et al. Multivariate data analysis. 6th edition. Upper Saddle River (NJ): Pearson-Prentice Hall, 2005
Moore WL, Gray-Lee J, Louviere JJ. A cross-validity comparison of conjoint analysis and choice models at different levels of aggregation. Marketing Letters 1998; 9: 195–207
Warkentin TE, Greinacher A, editors. Heparin-induced thrombocytopenia. New York: Marcel Dekker, 2004
Schoeffski O, Schulenburg J-M, Graf VD, editors. Evaluations in health economics [in German]. 3rd ed. Berlin: Springer, 2007
Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med 1992; 34: 507–13
Spahn G. Compliance with self administration of heparin injections in outpatients. Eur J Trauma 2002; 2: 104–9
Tribout B, Colin-Mercier F. New versus established drugs in venous thromboprophylaxis: efficacy and safety considerations related to timing of administration. Am J Cardiovasc Drugs 2007; 7: 1–15
The survey was financially supported by Boehringer Ingelheim. The author would like to thank an anonymous reviewer as well as Ms Silke Hastedt and Ms Dallas Reese for their very helpful comments. The study design, the collection/analysis/interpretation of the data, and the writing of the report was performed independently of the funder. The author has previously received honoraria from Boehringer Ingelheim.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Wilke, T. Patient Preferences for an Oral Anticoagulant after Major Orthopedic Surgery. Patient-Patient-Centered-Outcome-Res 2, 39–49 (2009). https://doi.org/10.2165/01312067-200902010-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/01312067-200902010-00005